Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

[1]  M. Silverberg,et al.  Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease , 2009, Gut.

[2]  J. Rioux,et al.  Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis , 2009, Gut.

[3]  P. Deloukas,et al.  Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. , 2009, Gastroenterology.

[4]  Steven Gallinger,et al.  Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer , 2008, Nature Genetics.

[5]  Inês Barroso,et al.  Population-Specific Risk of Type 2 Diabetes Conferred by HNF4A P2 Promoter Variants , 2008, Diabetes.

[6]  D. Strachan,et al.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.

[7]  Joshua M. Korn,et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs , 2008, Nature Genetics.

[8]  Joseph T. Glessner,et al.  Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease , 2008, Nature Genetics.

[9]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[10]  Alastair Forbes,et al.  Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease , 2008, Nature Genetics.

[11]  Kari Stefansson,et al.  Multiple genetic loci for bone mineral density and fractures. , 2008, The New England journal of medicine.

[12]  A. Zhernakova,et al.  Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. , 2008, American journal of human genetics.

[13]  T. Karlsen,et al.  Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis , 2008, Nature Genetics.

[14]  Scott F. Saccone,et al.  A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci , 2008, PLoS genetics.

[15]  F. Schmidt Meta-Analysis , 2008 .

[16]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[17]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[18]  Alastair Forbes,et al.  Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility , 2007, Nature Genetics.

[19]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[20]  Simon Heath,et al.  Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4 , 2007, PLoS genetics.

[21]  Thomas Lengauer,et al.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.

[22]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[23]  G. Konopka,et al.  Hepatocyte nuclear factor 4 (cid:1) orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver , 2006 .

[24]  K. Kaestner,et al.  Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. , 2006, Gastroenterology.

[25]  J. Chambaz,et al.  E-cadherin-dependent Transcriptional Control of Apolipoprotein A-IV Gene Expression in Intestinal Epithelial Cells , 2006, Journal of Biological Chemistry.

[26]  P. Tso,et al.  Apolipoprotein A-IV inhibits experimental colitis. , 2004, The Journal of clinical investigation.

[27]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[28]  P. J. Kelly,et al.  Inflammatory bowel disease: epidemiology and management in an English general practice population , 2000, Alimentary pharmacology & therapeutics.

[29]  S. Florian,et al.  Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa , 2000, International Journal of Colorectal Disease.

[30]  K. Syrigos,et al.  Expression of catenins and E‐cadherin during epithelial restitution in inflammatory bowel disease , 1998, The Journal of pathology.

[31]  D. Jewell,et al.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease , 1996, The Lancet.

[32]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[33]  Inês Barroso,et al.  Population-specific risk of type 2 diabetes ( T 2 D ) conferred by HNF 4 A P 2 promoter variants : a lesson for replication studies , 2008 .

[34]  K. Mossman The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[35]  M. Stoffel,et al.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.